연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2091. ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance.
Shin DY1,2, Park JK3, Kim SM4, Im K4, Kim JA5, Kim SY6, Hwang SM7, Yoon SS1,4, Lee DS4,5.
Leuk Lymphoma. 2018 Oct 10:1-8. doi: 10.1080/10428194.2018.1492129. [Epub ahead of print]
Link
2090. Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses.
Yoon BR, Oh YJ, Kang SW, Lee EB, Lee WW.
Front Immunol. 2018 Jan 25;9:53. doi: 10.3389/fimmu.2018.00053.
Link
2089. Senescent T Cells Predict the Development of Hyperglycemia in Humans.
Lee YH, Kim SR, Han DH, Yu HT, Han YD, Kim JH, Kim SH, Lee CJ, Min BH, Kim DH, Kim KH, Cho JW, Lee WW, Shin EC, Park S.
Diabetes. doi:10.2337/db17-1218. Epub 2018 Nov 2. PubMed PMID: 30389747.
Link
2088. Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: A prospective randomized trial.
Kong SH, Lee HJ, Na JR, Kim WG, Han DS, Park SH, Hong H, Choi Y, Ahn HS, Suh YS, Yang HK
Surgery. 2018 Dec;164(6):1263-1270
Link
2087. Androgen receptor inhibitor enhances the anti-tumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response
Ahrum Min, Hyemin Jang, Seongyeong Kim, Kyung-Hun Lee, Debora Keunyoung Kim, Koung Jin Suh, Yaewon Yang, Paul Elvin, Mark J. O`Connor, and Seock-Ah Im
Mol Cancer Ther. 2018 Dec;17(12):2507-2518
Link
2086. Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre,open-label, three-arm, randomised phase II trial (FLAGstudy)
Ji-Yeon Kim, Seock-Ah Im, Kyung Hae Jung, Jungsil Ro, Joohyuk Sohn, Jee Hyun Kim, Yeon Hee Park, Tae-Yong Kim, Sung-Bae Kim, Keun Seok Lee, Gun Min Kim, Se Hyun Kim, Seonwoo Kim, Jin Seok Ahn, Kyung-Hun Lee, Jin-Hee Ahn, In Hae Park, Young-Hyuck Im
Eur J Cancer. 2018 Nov;103:127-136
Link
2085. A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial
Yeon Hee Park, Kyung-Hun Lee, Joo Hyuk Sohn, Keun Seok Lee, Kyung Hae Jung, Jee-Hyun Kim, Ki Hyeong Lee, Jin Seok Ahn, Tae-Yong Kim, Gun Min Kim, In Hae Park, Sung-Bae Kim, Se Hyun Kim, Hye Sook Han, Young-Hyuck Im, Jin-Hee Ahn, Jung-Yong Kim, Jahoon Kang, Seock-Ah Im
Int J Cancer. 2018 Dec 15;143(12):3240-3247
Link
2084. Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells
Miso Lee, Kyung-Hun Lee, Ahrum Min, Jeongeun Kim, Seongyeong Kim, Hyemin Jang, Jee Min Lim, So Hyeon Kim, Dong-Hyeon Ha, Won Jae Jeong, Koung Jin Suh, Yae-Won Yang, Tae Yong Kim, Do-Youn Oh, Yung-Jue Bang, Seock-Ah Im
Cancer Res Treat. 2018 Jun 6. [Epub ahead of print]
Link
2083. Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells
Ahrum Min, Jung Eun Kim, Yu-Jin Kim, Jee Min Lim, Seongyeong Kim, Jin Won Kim, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Yung-Jue Bang, Seock-Ah Im
Cancer Lett.. 2018 Aug 28;430:123-132
Link
2082. Recent treatment patterns and survival outcomes in pancreatic cancer according to clinical stage based on single-center large-cohort data.
Lee DH1, Jang JY1, Kang JS1, Kim JR1, Han Y1, Kim E1, Kwon W1, Kim SW1.
J Hepatobiliary Pancreat Sci. 2018 Feb;25(2):124-130. doi: 10.1002/jhbp.520. Epub 2017 Dec 14.
Link